Eltrombopag tablet Online - Revolade | Apple pharmaceuticals

DESCRIPTION

Eltrombopag is a prescription drug which is used under the guidance of the doctor.
Eltrombopag drug may be used as part of combination therapy. Thereby drug may need to take it with other medications.

INDICATION

Eltrombopag is mainly indicated for the treatment of patients having :
• Reduced platelet levels due to chronic immune thrombocytopenia
• Reduced platelet counts due to chronic hepatitis C virus infection
• Severe Aplastic Anemia :
• First line treatment of severe Aplastic Anemia
• Treatment of refractory severe Aplastic Anemia

MECHANISM

Eltrombopag be part of a class of drugs called thrombopoietin (TPO) receptor agonists. Classification of drugs is an association of medications which work in a similar way. These drugs are often used to treat similar conditions. Eltrombopag works by raise cells in bone marrow and leads these cells to make various platelets. This effect reduces the risk of bleeding.

DOSAGE

Chronic Immune Thrombocytopenia :
Indicated only in patients with chronic immune thrombocytopenia whose clinical condition increases bleeding risk
Initial: 50 mg PO qDay
Adjust dose to achieve and control platelet count (Plt) >50 x 10^9/L to lowers risk of bleeding; not to exceed 75 mg/day Chronic Hepatitis C-associated Thrombocytopenia

COMMON SIDE EFFECTS

• low red blood cells
• nausea
• fever
• weakness
• pain in head
• cough
• decreased appetite
• flu
• diarrhea

PRECAUTION

The drug causes warning condition, call the doctor while new medication interaction Disease progression warning: Avoid using the drug while the patients have myelodysplastic syndrome (MDS), will increase the risk of death.
If other blood clot risk factors, then avoid the drug because it will increase platelet counts and blood clots.
If the patients have cataracts, avoid the drug due to the drug effects cataracts and make the condition worse.

DRUG INTERACTION

Eltrombopag interaction with these drugs ezetimibe, glyburide, Olmesartan, repaglinide, valsartan, imatinib, irinotecan, lapatinib, methotrexate, mitoxantrone, Bosentan, sulfasalazine, and topotecan irinotecan leads to an increase of side effects. hence the doctor may reduce your dosage of these drugs if required.

Eltrombopag co-administration with Cholesterol-reducing drugs like atorvastatin, fluvastatin, rosuvastatin, pravastatin, and simvastatin, pitavastatin. Have high side effects can contain muscle pain. The doctor may reduce the dosage of your cholesterol drugs.

STORAGE

Store at room temperature 20℃ and 25℃.
Discard the left-out medicine if not used within 30 minutes

MISSED DOSE

In case of a missed dose, patients must consult with a medical practitioner and follow the instructions given by them. thereby missed dose should be avoided and follow the regular dosing schedule.

FOR MORE INFORMATION:


EMAIL:


applepharmaceutical@gmail.com


PHONE:


91- 9987711567


Comments

Post a Comment

Popular posts from this blog

Cabozantinib (Cometriq, Cabometyx) tablet Online | Apple pharmaceuticals

DESCRIPTION Cabozantinib  which is a type of targeted therapy drug used to recover from medullary thyroid cancer and kidney cancer that has spread. Its label contains a black box warning of gastrointestinal perforations, fistulas, and hemorrhage. Cabozantinib is a prescription drug which is used under the supervision of doctors INDICATION Cabozantinib  is used for the treatment of metastatic medullary thyroid cancer and for the treatment of patients having advanced renal cell carcinoma (RCC) who have to get before anti-angiogenic therapy. MECHANISM Cabozantinib   is also called a tyrosine kinase inhibitor (targeted therapy drug). It works by prohibiting the signals inside cancer cells which made them grow and multiply. This may help to block or reduced the growth of cancer. It can also prohibit new blood vessels growing in cancer. Cancer cells require to make new blood vessels so they can develop and spread. DOSAGE MODIFICATION Avoid substitute  Caboz...
Read more

Evertor 10mg tablet - Everolimus | Myapplepharma

Description Evertor belongs to the class of anti-cancer drugs Evertor contains an active compound known as Everolimus which interferes with the development of cancer cell and the process is slowed down. Evertor tablets is not a curable medication, which helps to slow their spreading into the body. Prescribed For The drug Evertor is mainly indicated for the treatment of the following disease • kidney carcinoma • Breast carcinoma • Brain carcinoma Evertor is also used to treat in various advanced stage cancer in stomach, intestines or pancreas. Mechanism Evertor is a prohibition of mTOR, links at peak compatibility to FK506 binding protein 12, through producing drug complex which prevents the productive of mTOR, the main ingredient which is used as everolimus. This inhibition reduces the activity of effectors downstream, which may lead to stoppage of cell progression from G1 into S phase, Finally causes cell growth arrest and apoptosis Dosage regimen of Evertor In...
Read more

Everotas 5mg tablet - Everolimus | Myapplepharma

DESCRIPTION Everotas 5mg belongs to a class of anti-cancer drugs. Everotas 5mg contains an active compound known as Everolimus which interferes with the development of cancer cell and the process is slowed down. Everotas 5mg tablets is not a curable medication, which helps to slow their spreading into the body. PRESCRIBED FOR The drug Everotas 5mg is mainly used for the treatment of the following disease • kidney carcinoma • Breast carcinoma • Brain carcinoma Everotas 5mg is also used to treat in various advanced stage cancer in stomach, intestines or pancreas. CLINICAL PHARMACOLOGY OF EVEROTAS Everolimus is a prohibition of mTOR, links at peak compatibility to FK506 binding protein 12, through producing drug complex which prevents the productive of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to stoppage of cell progression from G1 into S phase, finally causes cell growth arrest and apoptosis. Everotas also prohibits the express...
Read more